Cancer vaccines poised to unlock ' new treatment paradigm ' with Merck/Moderna data
Adding an experimental mRNA-based vaccine from (NASDAQ: ) Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a mid-stage trial, the companies reported on Monday. With this and earlier data, Moderna is considering…#incandmerckco #moderna #stephenhoge #merck #keytruda #janehealy #merckmoderna #gritstonebioinc #roche #tecentriq
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Health | Immunotherapy | Merck | Skin | Skin Cancer | Vaccines